Glutamine is an essential amino acid for malignant tumor cells. Glutaminase that metabolizes glutamine reaches a maximum expression in tumors immediately before the maximum proliferation rate. Tumor cells grow at different rates during the day. We postulated that the activity of glutaminase in tumor cells is subject to the regulation of circadian clock gene. We measured glutaminase by western blot analysis and circadian clock gene expression by real-time polymerase chain reaction in the liver and tumor cells at six equispaced time points of the day in individual mice of a 12/12 h light/dark schedule. The results showed that the tumor-bearing mice, under normal diurnal conditions, are circadianly entrained, as reflected by the normal host locomotor activity rhythms and rhythmic liver clock gene expression. The tumors within these mice are also circadianly organized, as reflected by circadian clock gene (Bmal1) expression. What is most remarkable is that kidney-type glutaminase also showed circadian rhythms in the same pattern with tumor circadian clock gene expression in liver cancer xenograft model, indicating that conditionally inhibiting glutaminase activity may provide a new target for cancer therapy.
Introduction
The mitochondrial enzyme glutaminase (GA) catalyzes the hydrolysis of glutamine (Gln) into glutamate and ammonia [1] . Through this reaction and the subsequent conversion into a-ketoglutarate, Gln serves as a major source of tricarboxylic acid cycle intermediates that ultimately provide a large fraction of cellular energy and reducing equivalents in most cultured mammalian cells and tumor cells that are dependent on Gln. Tumor cells have been identified to consume most of the Gln and it is believed that most of the Gln utilized by tumor cells is driven by its enzymatic hydrolysis by GA [2] [3] [4] .
The GA family consists of two main members encoded by two separate genes, glutaminase gene (Gls) and glutaminase 2 gene (Gls2), located in different chromosomes [5] . The Gls gene encodes two isoforms, known as kidney (K-type) glutaminase or KGA [6] , and glutaminase C or GAC [7] . These two isoenzymes are usually referred to as kidney-type glutaminase (GLS) [8] . On the other hand, the Gls2 gene codes for two additional liver (L-type) isozymes, named as LGA [9] and GAB [10] , collectively referred to as GLS2 [11] . GLS is crucial for catabolizing Gln for rapid proliferating cancerous cells.
It was reported that most biological processes in mammals act in a rhythmic manner with respect to time of day for purposes of economy and survival [12] . Each cell in most of the peripheral tissues is regulated by circadian clock genes, and through direct autonomic nervous connection and/or circadianly organized hormonal signals, time-specific daily behaviors, and metabolic signals from meal timing, connected to central clock gene expression in the suprachiasmatic nuclei [13] [14] [15] .
Bmal1 [brain and muscle aryl hydrocarbon receptor nuclear translocator (ARNT)-like] is a major circadian clock gene expressed in various tissues. It encodes proteins regulating circadian rhythm. Bmal1 protein forms part of a basic helix-loop-helix transcription factor. Bmal1 dimerizes with the CLOCK gene (Circadian Locomotor Output Cycles Kaput, encoding a basic helix-loop-helix-PAS transcription factor) in vivo and trans-activates the gene expression of persistence and period in Drosophila by binding to the E-box elements in their promoters [16] .
In this study, we supposed that GA, as an important enzyme in tumor cell proliferation, might also be rhythmically
regulated by the circadian clock gene. We evaluated GLS, including its protein and mRNA expression as well as its enzyme activity, and circadian clock gene (Bmal1) expression in the liver and tumors resected from tumor-bearing mice at six equispaced time of day.
Materials and Methods
Animals and housing Four-to five-week-old female Balb/C mice were purchased from Shanghai Laboratory Animal Center and allowed to acclimate for 2 months prior to experiment. Mice were housed in rooms with regular lighting schedule of 12 h lights-on alternating with 12 h lights-off according to a previous report [17] . Time is referred to as Hours After Lights are On (HALO). All experiments were performed in compliance with the Guide for Care and Use of Laboratory Animals in Shanghai Jiaotong University.
Tumor cell inoculation
A human primary HCC cell line (BEL 7402) was obtained from Cell Engineering Center of Tongji Medical College (Huazhong University of Science and Technology, Wuhan, China). BEL 7402 cells were cultured in RPMI-1640 medium (Sigma, St Louis, USA) containing 100 ml/l of fetal bovine serum, and antibiotics ( penicillin, 10,000 U/ml and streptomycin, 10,000 mg/ml). Cells were incubated under humidified atmosphere at 378C with 5% CO 2 /95% air. Cells at exponential stage were collected by centrifugation at 1000 g for 10 min, and then resuspended in RPMI-1640 medium to make a 10 7 cell suspension. A total of 0.2 ml cell suspension was subcutaneously implanted into the flank of 48 nude mice by injection with aseptic technique. These tumors continue to grow locally until the animal dies.
Effect of tumor on circadian locomotor activity To assess general circadian organization of the tumorbearing host, mice were individually housed in cages with running wheels connected to computerized activity monitors for 2 weeks before tumor cell inoculation. Tumor cells were injected when the mice were accustomed to the wheels. The voluntary locomotor activity of each mouse and its circadian pattern were recorded and analyzed. Tumor size (diameter) was measured with calipers at the same biological time each day and at the end of the daily activity span (10 HALO).
Tumor and liver tissue collection After euthanasia, tumor and liver tissues were dissected from each mouse at six equispaced time of day in accordance with HALO. One part of tumor and liver tissues were placed into liquid nitrogen and stored in a 2808C freezer. The remaining tissues were fixed with 10% buffered formalin for 24 h and embedded in paraffin and stored at 48C.
Tumor tissue histopathological examination H&E sections from each tumor marking the most viable areas of the tumor tissue were examined by a trained clinical and experimental pathologist. Multiple 5 mm sections were cut from the array block and mounted on positively charged glass slides for histopathological examination to confirm the liver cancer.
Tumor and liver RNA extraction Total RNA was isolated from the frozen tumor and liver tissues using Trizol reagent (Genlab, Shanghai, China). Briefly, the tumor and liver tissues (20-30 mg) were homogenized in 5 ml Trizol reagent and mixed vigorously with 1 ml chloroform for 15 s. The mixtures were then centrifuged at 10,000 g at 48C for 15 min. The aqueous phases were transferred to fresh tubes. Isopropyl alcohol was then added (2.5 ml/tube) and mixed. The tubes were allowed to stand at room temperature for 20 min and then centrifuged at 10,000 g at 48C for 10 min. RNA pellets were washed with 5 ml pre-chilled 70% alcohol and dissolved in 50-100 ml of diethyl pyrocarbonate-treated water. The RNA concentration was determined using a spectrophotometer (FP-640; Aoxi, Shanghai, China). All RNA samples were checked for integrity by RNA agarose gel electrophoresis.
RNA reverse transcription
To synthesize the first strand of the cDNA template, 5 mg of the total RNA was reversely transcribed in a final volume of 20 ml reaction system, which contained Moloney Murine Leukemia Virus reverse transcriptase and 0.2 pmol of antisensespecific primers RT-GLS for the GLS transcript (RT-GLS, 5 0 -TCCAAGCTAGGTAACAGACCCT-3 0 ), 1 mM dNTPs, 40 U RNase inhibitor, and 300 ng oligo d(T) 12-18 (Genlab). The reaction was performed at 378C for 50 min, followed by extension at 708C for 15 min, and 48C for 5 min.
Real-time polymerase chain reaction Real-time polymerase chain reaction (PCR) analysis was performed with an iCycler IQ real-time PCR detection system (Bio-Rad, Hercules, USA). Intron-spanning primers were designed using Primer Express 2.0 software. The primer pairs used for the amplification of each gene were as follows: Bmal1:
0 ; and GLS: 5 0 -TCCAAGCTAGGTAACAG ACCCT-3 0 /5 0 -ATGCCTCCATCTGCTGCCCAG-3 0 . All PCR reagents were purchased from Genlab. PCR was performed according to the manufacturer's protocol. For each sample, the amount of target gene expression (Bmal1 and GLS) and housekeeping gene expression (S16 ribosomal protein gene) was determined based upon the threshold cycle.
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The content of the target gene expression was evaluated with respect to that of the housekeeping gene in each sample and expressed as the ratio of the target gene to the reference gene. Each tumor and liver sample was tested in triplicate and the sample size was four. Multiple no-template controls were included in all sets of PCR amplification to test for the possible contamination of PCR reagents.
Western blot analysis for GA GA proteins in total tissue extracts were subject to western blot analysis. Tumor and liver tissue extracts were washed twice with ice-cold phosphate buffered saline, and lysed with ice-cold RIPA buffer [30 mM HEPES, 150 mM NaCl, 1.0% (v/v) Triton X-100, 0.1% (w/v) sodium dodecyl sulfate (SDS), and 1.0% (w/v) deoxycholic acid, pH 7.6], supplemented with proteinase inhibitors, pepstatin A (1.0 mg/ml), leupeptin (10 mg/ml), and 0.2 mM Phenylmethanesulfonyl fluoride. Lysates were clarified by centrifugation at 10,000 g for 10 min at 48C. Protein (25 mg/lane) was electrophoresed on 10% SDS-polyacrylamide gels and transferred onto nitrocellulose membranes. The membranes were incubated with a rabbit anti-rat renal GA polyclonal antibody and then with a goat anti-rabbit IgG-biotin and avidin-peroxidase antibody. GA bands were detected by using diaminobenzidine as a substrate.
GA activity assay
Phosphate-activated GA activities were determined as follows: harvested tissue extracts were washed three times with 0.1 M Tris-HCl, pH 8.0, and suspended in the same buffer for 3 h in order to deplete endogenous substrates. The reaction medium were 0.1 M phosphate, 20 mM Gln, 20 mg/ ml oligomycin, and 1.2 mg/ml antimycin A to prevent mitochondrial glutamate oxidation. Under these conditions, Gln and phosphate are at saturating concentrations. After 6 min incubation at 378C, the reaction was stopped by the addition of 0.5 ml of 0.4 M HCl. After being neutralized with KOH, the mixture was centrifuged at 16,000 g for 5 min. Finally, the glutamate formation was determined by previous method [18] . Controls without phosphate and blank samples were also run in parallel.
Statistical analysis
Data were expressed as the mean plus minus standard deviation. Comparison of the mean across six circadian times of day (HALO) was assessed by one-way analysis of variance (SigmaPlot 9.0, SYSTAT Software). Statistical significance was considered when P , 0.05. Data based upon the six circadian time periods were graphed as a double plot over 48 h with standard errors of the mean, as is customarily done to visualize recurrent rhythmic patterns more easily.
Results
Circadian locomotor cycle of normal and tumor-bearing mice Voluntary wheel-running locomotor activity was measured before and after liver cancer cell inoculation by continually recording wheel-running activities of individual mice. Normal mice, prior to tumor cell inoculation, took 9-10 days to establish a stable daily running pattern. The locomotor activities of tumor-bearing mice were maintained at normal levels with clear maintenance of circadian rhythmic pattern throughout the observation span. Mice with middle stage tumors (days 13-17) showed normal circadian activity patterns, with no difference in 24 h circadian period under light and dark schedule and 24 h mean activity levels during usual diurnal span (measure of disturbance), which is contrasted to their own individual and group wheel-running data during the week long interval prior to tumor inoculation ( Table 1) .
Rhythmic expression of circadian clock genes in tumor and liver tissue
Previous studies in normal mice have described clock gene rhythms in liver [10, 11] . Bmal1 expression in tumors varies significantly throughout the day ( Fig. 1, P , 0.01) . The circadian pattern of the tumor Bmal1 gene expression is similar to Bmal1 daily rhythm in host liver, showing a peak expression at around 20 : 00 HALO and a trough at around 8 : 00 HALO ( Fig. 2, P , 0.01 ), but the tumor Bmal1 gene expression peaks a little later. The daily fold difference between peak and trough of Bmal1 expression in liver was 13.6 + 5.4 folds, while that in tumor was 3.1 + 1.3 folds. The expression of Bmal1 in the liver is much higher than that in tumor.
GA activity in tumor and liver tissue
Western blot analysis results revealed GLS expression in tumor but not in mice liver, and GLS mRNA exists only in the tumor but not in the mice liver. These results confirmed that renal-type GA was present in liver carcinoma but not in No difference was found in the mice activities of light-on and light-off rotation before and after tumor implantation.
Circadian clock gene expression regulates cancer cell growth mice liver (Fig. 3A) . The results also showed a rhythmic change of the level of GLS mRNA within the day. It peaked once at 20 : 00 and decreased to nadir at 08 : 00 (Fig. 3B) , and the daily fold difference is 1.73 + 0.8 folds. GA activities as demonstrated by glutamate formation also showed rhythmic changes in the tumor tissue. GLS activity (Fig. 4) in tumor showed similar circadian pattern with that of GLS2 in the liver (Fig. 5) . The daily fold change of GLS is 2.6 + 0.8 mU in the tumor, and GLS2 is 3.0 + 0.9 mU in the liver.
Discussion
Our results showed that the levels of GLS mRNA and its activity in tumor cells have the same pattern of rhythmic changes within the day. This multiple fold changes within the day is in accordance with the circadian clock gene expression, suggesting that circadian gene coordinates GLS expression, resulting in the increased utilization of Gln for cancerous cell proliferation as demonstrated by increased GA activity. Several randomized clinical trials and extensive animal studies have confirmed that the timing, within the day, of cancer chemotherapy affects the proportion of the tumor-bearing mice cured [19] . The toxicity of cancer Circadian clock gene expression regulates cancer cell growth chemotherapy, as well as the control of human cancer, have been improved by the optimal circadian timing of cancer chemotherapy [19] . Our results suggested that inhibiting GLS expression during its high expression period might suppress the growth of cancer; this timing therefore, might reduce the toxic effects when traditional methods are used unconditionally, which may provide a new method for cancer therapy.
In the 1980s, two Gln-related anti-neoplastic therapies raised great expectations, i.e. Gln clearance and the use of Gln analogs to kill tumor cells by exhausting their provision of Gln. The results were disappointing due to multiple toxic effects and lack of specificity and/or ineffectiveness of the treatments [20] . Recent studies of the small molecule 968 BPTES, a dibenzophenanthridine, has shown that it could inhibit the expression of GA, block the proliferation and anchorage-independent colony formation of human cancer cells in culture, and inhibit tumor formation in mouse xenograft models. Drug companies are currently developing GA inhibitors for use in trials, though its clinical effects and toxicity are still under evaluation [21, 22] .
In the present study, western blot analysis showed GLS expression in the tumor and not in the mice liver, and GLS mRNA also existed only in the tumor and not in the mice liver, therefore confirmed that GLS was present in the implanted liver carcinoma. Our study showed that a HepG2 hepatoblastoma cell line expresses the GLS isoenzyme [23] .
The following lines of evidence should be considered for hepatocellular transformation: (i) rat hepatoma cells express GLS [24] ; (ii) fetal hepatocytes express the GLS isoform, and shortly after the child is born, there is a loss of GLS expression, whereas GLS2 begins to express [9] ; (iii) normal non-proliferating hepatocytes express the GLS2 isoenzyme [24] ; and (iv) human hepatoma cells, similar to HepG2, express both isoforms, although GLS seems to account for most of the GA activity. Therefore, it is tempting to speculate that the process of malignant transformation shifts the pattern of GA expression in such a way that GLS isoenzyme becomes up-regulated; in other words, transformed liver cells, like liver cancer cell and HepG2, return to a fetal-like phenotype, characterized by a higher rate of cell proliferation and prevalence of GLS expression.
The high rates of protein synthesis in rapidly growing tumors require a continuous supply of both essential and non-essential amino acids [22] . Tumors use the incorporated amino acids for both oxidation and protein synthesis. Because Gln is the most abundant amino acid in the body and the main vehicle for circulation of ammonia in a non-toxic form, some researchers considered that tumors behave as Gln traps. Tumors elicit a specific response in the host nitrogen metabolism, i.e. to mobilize and augment circulating Gln. There is a net flux of Gln from the host to tumor [23] . In the mitochondria, Gln is acted upon by GA, an enzyme requiring high phosphate concentrations to be fully active. The high concentrations of inorganic phosphate found in the mitochondria of tumor cells could explain the high activity of tumor GA in vivo. In fact, experimental evidence supports the correlation of GA activity with the extent of malignant proliferation. Tumor GA reaches a maximum expression and activity immediately before the maximum proliferation rate [24] .
In conclusion, our study showed that GA gene and enzyme activity in tumor cells are in accordance with circadian clock gene expression as the normal liver cells, indicating that circadian clock gene expression regulates cancer cell growth through GA. These data suggested that conditionally inhibiting GA activity may provide a new target for liver cancer therapy.
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